Toyobo (3101): FY2025 Results Summary — Operating Profit Up 67.6% on Films Recovery; Next-Year Forecast Undetermined

This article is based on publicly available IR materials and is not a recommendation to buy or sell any specific securities.

Toyobo reported significant profit growth for the year ended March 31, 2026, driven by strong performance in Films, Environmental and Functional Materials, and Functional Textiles and Trading, despite lower profit in Life Science. Net sales were essentially flat at ¥421.6 bn. (-0.1%), while operating profit rose 1.7 times year on year to ¥27.9 bn. (+67.6%) and profit attributable to owners of parent reached ¥11.2 bn. Both figures came in above the company’s own previous forecast (Feb. 2026). The annual dividend was ¥40 per share.

Note: Toyobo’s fiscal year ends March 31. This article covers the fiscal year ended March 31, 2026, which the company labels “FY 3/26” and which this site classifies as FY2025 under its year-labeling convention. All figures and labels in the body and tables below follow the company’s presentation exactly (e.g., “FY 3/26” for the year just ended and “FY 3/27” for the current year).

Consolidated Results (Full-Year Actual)

Gross profit improved to ¥108.2 bn. (+11.4%), with the ratio to sales rising to 25.7% from 23.0%. Operating profit margin expanded to 6.6% from 3.9%. Ordinary profit more than doubled to ¥22.9 bn. (+116.0%), and EBITDA rose to ¥52.5 bn. (+33.5%). EPS was ¥126.7, ROE 5.5%, and ROIC 3.8%. Figures are in ¥ bn. unless noted.

Item	FY 3/26	FY 3/25	YoY
Net sales	421.6	422.0	-0.1%
Gross profit	108.2	97.1	+11.4%
(Gross margin)	25.7%	23.0%	–
Operating profit	27.9	16.7	+67.6%
(Operating margin)	6.6%	3.9%	–
Ordinary profit	22.9	10.6	+116.0%
Profit attributable to owners of parent	11.2	2.0	+9.2
EBITDA	52.5	39.4	+33.5%
EPS (¥)	126.7	22.7	–
ROE	5.5%	1.0%	–
ROIC	3.8%	2.3%	–

Segment Results

Films led the improvement, with operating profit up ¥9.7 bn. to ¥16.6 bn. as packaging film earnings recovered on higher productivity of the new facility and industrial film sales (polarizer protective films for LCDs and mold releasing film for AI servers) were strong. Environmental and Functional Materials operating profit rose to ¥9.7 bn. (+¥1.7 bn.), and Functional Textiles and Trading rose to ¥1.3 bn. (+¥0.7 bn.). Life Science operating profit fell to ¥0.1 bn. (-¥1.9 bn.), hurt by weaker biotechnology earnings, including sluggish diagnostic reagent sales amid China market conditions and lower overseas sales.

Segment	Net sales FY 3/26	Net sales FY 3/25	Operating profit FY 3/26	Operating profit FY 3/25
Films	175.2	166.8	16.6	6.9
Life Science	34.5	34.3	0.1	2.0
Environmental and Functional Materials	110.1	110.8	9.7	8.0
Functional Textiles and Trading	89.6	98.1	1.3	0.5
Real Estate and Others	12.2	12.0	3.2	2.6
Elimination & Corporate	–	–	-2.9	-3.3
Total	421.6	422.0	27.9	16.7

Actual vs. Previous Forecast (Feb. 2026)

Full-year results exceeded the company’s most recent previous forecast (announced Feb. 2026) across profit lines, even as net sales came in slightly below plan.

Item (¥ bn.)	FY 3/26 Actual	Previous Forecast (Feb. 2026)
Net sales	421.6	430.0
Operating profit	27.9	24.0
Ordinary profit	22.9	19.5
Profit attributable to owners of parent	11.2	8.5
EBITDA	52.5	48.5
EPS (¥)	126.7	96.4

Next-Year Forecast (FY 3/27)

Due to the prolonged unrest in the Middle East, the company expects impacts from disruption in the supply of oil and naphtha-derived raw materials along with soaring prices. As the outlook is difficult to predict and its impact on business cannot be appropriately and reasonably calculated at this time, the consolidated earnings forecasts and dividend forecasts for the fiscal year ending March 31, 2027 (FY 3/27) are undecided. The company states it will announce them promptly once a reasonable calculation becomes possible.

Shareholder Returns

The dividend for FY 3/26 will be ¥40 per share. The dividend forecast for FY 3/27 is undecided at this time, for the same reasons as the earnings forecast.

Item	FY 3/26
Dividend per share	¥40

Management Policy and Topics (FY 3/27)

For FY 3/27, Toyobo’s management policy centers on: thorough safety/disaster prevention, quality and compliance; realizing results from investment (CAPEX and development); ensured pricing commensurate with value; improvement of capital efficiency (measures for challenged businesses and shorter CCC); and narrowing down of investment and expenses, realization of TX (Toyobo-transformation), and cost reduction, plus emergency response to geopolitical risk. Against rising Middle East tensions, short-term measures include securing supply chains and ample funds and organized price reviews, while medium-term measures include decentralizing procurement and logistics, portfolio reform, and strengthening the financial structure.

This article is an analysis based on publicly available information and is not a recommendation to buy or sell any specific securities. Investment decisions are your own responsibility.